MicroRNA-21 Protects Hypoxic-Induced Cardiomyocytes Injury by Targeting Smad-7
Cells · 2025
DOI: 10.3390/cells14191483 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Md Sayed Ali Sheikh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, College of Medicine, Jouf University, Sakaka 72345, Saudi Arabia. Hauptthemen laut MEDLINE: MicroRNAs, Myocytes, Cardiac, Smad7 Protein. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jouf University, Deanship of Scientific Research at Jouf University.
Abstract (Originalsprache)
Globally acute myocardial infarction is the leading independent cause of unexpected death. This study aimed to explore the diagnostic and molecular impact of miR-21, miR-488, and miR-126 in acute myocardial infarction patients (AMI). We enrolled 95 non-ST-elevation myocardial infarction (NSTEMI) patients, 152 ST-elevation myocardial infarction (STEMI) patients, and 95 healthy individuals, additionally using three-month-old mice and their ventricular-derived H9c2 cells. The circulatory plasma miR-21 and miR-488 levels were significantly upregulated, while plasma miR-126 levels were remarkably downregulated in NSTEMI and STEMI subjects. The receiver operating characteristic curve showed that plasma miR-21, miR-488, and miR-126 were able to clearly differentiate NSTEMI and STEMI from healthy subjects. Moreover, H9c2 hypoxic cells treated with inhibitor miR-21 markedly reduced intracellular ROS levels, capase-3 activities levels, and cellular apoptosis rates and significantly enhanced cellular viability through up regulation of Smad-7 mRNA and protein expressions. In geriatric STEMI and NSTEMI subjects, plasma miR-21 levels were evidently higher than in comparatively younger subjects. Upregulated plasma miR-21 and miR-488 levels and downregulated miR-126 levels might be considered potential clinical biomarkers for myocardial infarction patients, while inhibition of miR-21, which significantly reduced hypoxia-exposed H9c2 cellular injury via targeting Smad-7, could be a new therapeutic target for AMI patients. Low levels plasma miR-21 may have a significant impact on delaying the aging process.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Internal Medicine Department, College of Medicine, Jouf University, Sakaka 72345, Saudi Arabia.
- Gynecology and Obstetrics Department, College of Medicine, Jouf University, Sakaka 72345, Saudi Arabia.
Förderung
- Jouf University
- Deanship of Scientific Research at Jouf University
Zitieren
APA
Ali Sheikh, M. S., Alduraywish, A., Mohammed Alomair, B., Almubarak, M., & Salma, U. (2025). MicroRNA-21 Protects Hypoxic-Induced Cardiomyocytes Injury by Targeting Smad-7. Cells. https://doi.org/10.3390/cells14191483
Vancouver
Ali Sheikh MS, Alduraywish A, Mohammed Alomair B, Almubarak M, Salma U. MicroRNA-21 Protects Hypoxic-Induced Cardiomyocytes Injury by Targeting Smad-7. Cells. 2025. doi:10.3390/cells14191483
BibTeX
@article{AliSheikh2025,
author = {Ali Sheikh, Md Sayed and Alduraywish, A and Mohammed Alomair, Basil and Almubarak, Muhannad and Salma, Umme},
title = {MicroRNA-21 Protects Hypoxic-Induced Cardiomyocytes Injury by Targeting Smad-7},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14191483}
}
EUVIMED